Table 4 Assay of commercial tablet formulations
Tablets | % of the labelled claim | |
|---|---|---|
AS | AQH | |
Coarsucam®; 25 mg AS – 88.16 mg AQH (67.5 mg AQ base) | 101.6 | 99.6 |
Coarsucam®; 50 mg AS – 176.32 mg AQH (135 mg AQ base) | 98.1 | 100.2 |
Coarsucam®; 100 mg AS – 352.64 mg AQH (270 mg AQ base) | 97.0 | 98.1 |
ASAQ Denk®; 100 mg AS – 352.64 mg AQH (270 mg AQ base) | 98.0 | 99.5 |